Health Care Select Sector SPDR Fund (XLV)
| Assets | $41.15B |
| Expense Ratio | 0.09% |
| PE Ratio | 25.67 |
| Shares Out | 270.52M |
| Dividend (ttm) | $2.27 |
| Dividend Yield | 1.50% |
| Ex-Dividend Date | Sep 23, 2024 |
| Payout Ratio | 38.47% |
| 1-Year Return | +16.61% |
| Volume | 3,620,916 |
| Open | 151.37 |
| Previous Close | 150.97 |
| Day's Range | 151.25 - 152.03 |
| 52-Week Low | 122.59 |
| 52-Week High | 159.64 |
| Beta | 0.68 |
| Holdings | 64 |
| Inception Date | Dec 16, 1998 |
About XLV
Fund Home PageThe Health Care Select Sector SPDR Fund (XLV) is an exchange-traded fund that is based on the Health Care Select Sector index. The fund tracks health care stocks from within the S&P 500 Index, weighted by market cap. XLV was launched on Dec 16, 1998 and is issued by State Street.
Top 10 Holdings
57.32% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 12.56% |
| UnitedHealth Group Incorporated | UNH | 9.80% |
| Johnson & Johnson | JNJ | 6.92% |
| AbbVie Inc. | ABBV | 6.16% |
| Merck & Co., Inc. | MRK | 4.99% |
| Thermo Fisher Scientific Inc. | TMO | 4.10% |
| Abbott Laboratories | ABT | 3.52% |
| Danaher Corporation | DHR | 3.11% |
| Amgen Inc. | AMGN | 3.08% |
| Intuitive Surgical, Inc. | ISRG | 3.07% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 23, 2024 | $0.57723 | Sep 25, 2024 |
| Jun 24, 2024 | $0.57253 | Jun 26, 2024 |
| Mar 18, 2024 | $0.52294 | Mar 21, 2024 |
| Dec 18, 2023 | $0.59773 | Dec 21, 2023 |
| Sep 18, 2023 | $0.53952 | Sep 21, 2023 |
| Jun 20, 2023 | $0.54244 | Jun 23, 2023 |
News
Final Trades: Palo Alto Networks, Delta Air Lines, PayPal and the XLV
The Investment Committee give you their top stocks to watch for the second half.
XLV: Healthcare Outperforming In The Second Half, Bullish Tailwinds Persist
I am bullish on the Health Care Select Sector SPDR ETF (XLV) due to its attractive valuation, strong technical setup, and favorable seasonality heading into Q4. Eli Lilly (LLY) is a standout component...
Healthcare Stocks Have Popped. Consider These 2 That Haven't.
Money has poured into the sector as markets have grown concerned about the economy.
Charting the next health care stocks to break out
Chris Verrone, Strategas head of technical and macro research, joins 'Fast Money' to give his health care playbook.
The Highest Quality Dividend-Growth Healthcare Stocks
Quality Snapshots evaluate dividend-growth companies based on five quality factors including financial performance, resilience and dividend safety. This healthcare sector overview identifies 26 top qu...
Disruptive Theme of the Week: Playing Defense
When markets correct, it is a good time to revisit which equity market sectors are “defensive” themes. Certain products and services are nondiscretionary in nature that we cannot live without.
Healthcare Stocks Are Closing the Gap. Here Are the Latest Winners.
After trailing the broader market, this week's selloff has allowed healthcare stocks to nearly catch up.
Stock Of The Day: XLV Shatters Resistance Barrier, Establishes New Support Level
The chart of the Health Care Select Sector SPDR Fund XLV offers two valuable technical analysis lessons.
XLV: A Strong Way To Benefit From An Aging And Unhealthy Population
Demand for Health Care services is inelastic and expected to grow due to aging population and economic slowdown. XLV ETF provides cheap investment in healthcare companies across various sub-sectors li...
Final Trades: Qualcomm, Apple, Adobe and the XLV
The Investment Committee gives you their top stocks to watch for the second half.
Final Trades: Leidos, Oracle, Cheniere Energy and the XLV
The Investment Committee share their top plays for the second half.
CEF Report | May 2024 | Activism Is Heating Up
Taxable bond CEF space value shrinking as discounts tighten. Opportunities exist, especially following activists. Focus on top-down assessment, cheap sectors, and specific funds like Cohen & Steers Se...
XLV: Healthcare Is Ripe For Buying, Despite Patent Cliff
The healthcare sector is one that exhibits "inelastic demand" and has the unique advantage of being essential to peoples' lives. Healthcare's valuation has been stunted by risks such as the "patent cl...
Why investors are 'piled in' to healthcare stocks
Aaron Dunn, co-head of value equity at Morgan Stanley Investment Management, joins CNBC's 'The Exchange' to discuss opportunities in healthcare, why he thinks the sector is undervalued, and more.
XLV: Pivotal Week Of Earnings For Healthcare Stocks
A trio of top 10 holdings from this S&P 500 healthcare sector ETF report this week (LLY, the largest holding, PFE and AMGN). Despite being loaded with quality businesses, this sector is not showing si...
The Investment Committee's Pullback Playbook: Nvidia, Applied Materials, Apple, Uber, XLF and XLV
The Investment Committee share their pullback playbook for today's down market.
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.
How a Biden-Trump rematch can keep healthcare ETFs afloat this election year
Hello! This is MarketWatch reporter Isabel Wang bringing you this week's ETF Wrap. In this week's edition, we look at healthcare ETFs, which have taken a breather at the start of April, pausing their ...
This was a hot and promising sector for 2024. That's over, says one strategist.
Much chatter has been devoted to what's needed for the U.S. stock market rally to continue this year. A big one on the to-do list?
XLV: Fundamentals Don't Support Overweighting Health Care
XLV tracks the 64 Health Care stocks in the S&P 500 Index. Its expense ratio is 0.10% and the ETF has over $40 billion in assets under management. With a 12% weighting in the S&P 500 Index, Health Car...
Healthcare Investors Aren't Scared of Trump or Biden
Health stocks are off to their best start since 2017, despite a history of underperformance in election years.
Why Biotech Stocks May Be Ready For A Recovery
Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stoc...
Health care has more upside ahead, says BTIG's Jonathan Krinsky
Jonathan Krinsky, BTIG chief market technician, joins 'Closing Bell' to discuss his call for tech exhaustion ahead.
XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance
Health Care Select Sector SPDR Fund is recommended as a buy due to its strong mix of holdings, low expense ratio, and noteworthy dividend yield. XLV has outperformed its peer health care ETFs in terms...